Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Repligen Corp shares valued at $3,508,389 were sold by Hunt Anthony on Sep 10 ’25. At $120.52 per share, Hunt Anthony sold 29,111 shares. The insider’s holdings dropped to 100,743 shares worth approximately $15.06 million following the completion of this transaction.
Also, Hunt Anthony purchased 29,111 shares, netting a total of over 3,508,378 in proceeds.
Before that, Madaus Martin D had added 1,800 shares to its account. In a trade valued at $201,830, the Director bought Repligen Corp shares for $112.13 each. Upon closing the transaction, the insider’s holdings increased to 1,800 shares, worth approximately $0.27 million.
As published in their initiating research note from HSBC Securities on October 01, 2025, Repligen Corp [RGEN] has been a Buy and the price target has been revised to $150. Analysts at Evercore ISI upgraded the stock from ‘”an In-line”‘ to ‘”an Outperform”‘ outlook in a report released in late September. Earlier on June 24, 2025, Barclays initiated its rating. Their recommendation was “an Overweight” for RGEN stock.
Analyzing RGEN Stock Performance
On last trading session, Repligen Corp [NASDAQ: RGEN] rose 0.75% to $149.52. The stock’s lowest price that day was $147.16, but it reached a high of $152.36 in the same session. During the last five days, there has been a drop of approximately -0.86%. Over the course of the year, Repligen Corp shares have jumped approximately 7.71%.
Is Repligen Corp subject to short interest?
Stocks of Repligen Corp saw a sharp steep in short interest on 2025-09-30 dropping by -0.21 million shares to 3.41 million. Data from Yahoo Finance shows that the short interest on 2025-08-29 was 3.62 million shares. A decline of -6.14% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 4.15 of the overall float, the days-to-cover ratio (short ratio) decline to 4.15.
Which companies own the most shares of Repligen Corp (RGEN)?
In terms of Repligen Corp share price expectations, FactSet research, analysts set an average price target of 160 in the next 12 months, up nearly 7.82% from the previous closing price of $148.4. Analysts anticipate Repligen Corp stock to reach 205 by 2025, with the lowest price target being 150. In spite of this, 9 analysts ranked Repligen Corp stock as Buy at the end of 2025. On April 29, 2025, Wolfe Research assigned a price target of “an Outperform” to the stock and upgraded coverage with a $160.
